New Zealand markets closed

Cann American Corp. (CNNA)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0024-0.0006 (-20.00%)
At close: 03:15PM EDT

Cann American Corp.

320 Santana Drive
Suite C
Cloverdale, CA 95425
United States
770-866-6250
https://www.cannamericancorp.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full-time employees1

Key executives

NameTitlePayExercisedYear born
Mr. Jason R. TuckerPresident, CFO, CEO, Secretary, Treasurer & DirectorN/AN/A1977
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Cann American Corp., a development stage company, focuses on the development of Cannabis sativa strains for pets in various European Union countries. The company was formerly known as Canamed4Pets, Inc. and changed its name to Cann American Corp. in December 2019. Cann American Corp. was founded in 2004 and is based in Cloverdale, California.

Corporate governance

Cann American Corp.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.